Conventional medical therapies in patients with heart failure across different risk for transthyretin amyloid cardiomyopathy in the DELIVER, PARAGON-HF and TOPCAT Americas trials

11 May 2024 (15:00 - 15:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 10 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)